Information:
Error:
ID
18482
Description
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure; ODM derived from: https://clinicaltrials.gov/show/NCT00109655
Link
https://clinicaltrials.gov/show/NCT00109655
Keywords
Versions (1)
- 11/7/16 11/7/16 -
Uploaded on
November 7, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Carcinoma, Transitional Cell NCT00109655
Eligibility Carcinoma, Transitional Cell NCT00109655
- StudyEvent: Eligibility
Similar models
Eligibility Carcinoma, Transitional Cell NCT00109655
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Carcinoma of urinary bladder, invasive; Neoplasm Grading
Item
high grade non-muscle invasive bladder cancer (stages ta, t1 and/or cis - carcinoma in situ). high grade being defined as g2 or g3 disease.
boolean
C1827293 (UMLS CUI [1,1])
C3179006 (UMLS CUI [1,2])
C3179006 (UMLS CUI [1,2])
Bacillus Calmette-Guerin; cancer treatment
Item
failure of at least one prior treatment with bcg, defined as evidence of tcc on cystoscopic exam and biopsy or cystoscopic exam and urine cytology at least 6 weeks from last bcg treatment
boolean
C0085957 (UMLS CUI [1,1])
C0920425 (UMLS CUI [1,2])
C0920425 (UMLS CUI [1,2])
ECOG performance status
Item
ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Bone Marrow | Renal function | Liver function | Blood coagulation
Item
adequate bone marrow, renal, liver and coagulation function
boolean
C0005953 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0005778 (UMLS CUI [4])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
C0005778 (UMLS CUI [4])
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
hiv positive
boolean
C0019699 (UMLS CUI [1])
Anticoagulants
Item
use of anticoagulants such as coumadin or heparin
boolean
C0003280 (UMLS CUI [1])
Bleeding Risk
Item
history of bleeding disorder
boolean
C3251812 (UMLS CUI [1])
Autoimmune Diseases | Immunologic Deficiency Syndromes
Item
active systemic autoimmune disease or chronic immunodeficiency
boolean
C0004364 (UMLS CUI [1])
C0021051 (UMLS CUI [2])
C0021051 (UMLS CUI [2])
gene therapy
Item
prior gene therapy
boolean
C0017296 (UMLS CUI [1])
Cystitis | Bladder pain | Bladder spasm | Urinary Incontinence | Reduced bladder capacity
Item
uncontrolled cystitis, bladder pain, bladder spasms, urinary incontinence, or reduced bladder volume
boolean
C0010692 (UMLS CUI [1])
C0232849 (UMLS CUI [2])
C0426390 (UMLS CUI [3])
C0042024 (UMLS CUI [4])
C2721720 (UMLS CUI [5])
C0232849 (UMLS CUI [2])
C0426390 (UMLS CUI [3])
C0042024 (UMLS CUI [4])
C2721720 (UMLS CUI [5])